We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

111 hedge funds and large institutions have $225M invested in Arena Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $1.17M | Put options by funds: $931K

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

8% less capital invested

Capital invested by funds: $245M → $225M (-$19.6M)

8% less funds holding

Funds holding: 121 → 111 (-10)

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

Holders
111
Holders Change
-10
Holders Change %
-8.26%
% of All Funds
2.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
39
Reduced
35
Closed
16
Calls
$1.17M
Puts
$931K
Net Calls
+$240K
Net Calls Change
-$861K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.79M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.08M
3
RCM
RA Capital Management
Massachusetts
+$1.04M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$869K
5
QIM
Quantitative Investment Management
Virginia
+$254K

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$19.9M
2
Millennium Management
Millennium Management
New York
-$3.11M
3
State Street
State Street
Massachusetts
-$1.98M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.95M
5
AC
Ascend Capital
California
-$1.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
QI
26
QS Investors
New York
$610K – – –
CS
27
Credit Suisse
Switzerland
$601K +$167K +10,444 +52%
Goldman Sachs
28
Goldman Sachs
New York
$541K -$7.47K -466 -2%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$490K +$2K +125 +0.5%
Deutsche Bank
30
Deutsche Bank
Germany
$474K +$125K +7,827 +48%
Cambridge Investment Research Advisors
31
Cambridge Investment Research Advisors
Iowa
$455K +$15.1K +940 +4%
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$435K – – –
BG
33
BlackRock Group
United Kingdom
$417K +$47.4K +2,960 +16%
ProShare Advisors
34
ProShare Advisors
Maryland
$413K -$33.5K -2,090 -9%
CCMH
35
Cornerstone Capital Management Holdings
New York
$398K -$430K -26,854 -57%
State Board of Administration of Florida Retirement System
36
State Board of Administration of Florida Retirement System
Florida
$392K – – –
Citigroup
37
Citigroup
New York
$373K +$250K +15,624 +475%
QIM
38
Quantitative Investment Management
Virginia
$364K +$254K +15,870 +606%
MLICM
39
Metropolitan Life Insurance Company (MetLife)
New York
$343K +$3.17K +198 +1%
NFA
40
Nationwide Fund Advisors
Ohio
$317K -$10.6K -663 -4%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$310K +$4.34K +271 +2%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$301K -$72.1K -4,500 -23%
UBS AM
43
UBS AM
Illinois
$236K -$5.96K -372 -3%
Janney Montgomery Scott
44
Janney Montgomery Scott
Pennsylvania
$222K – – –
VOYA Investment Management
45
VOYA Investment Management
Georgia
$222K – – –
BA
46
BlackRock Advisors
Delaware
$221K +$12.9K +803 +8%
Wells Fargo
47
Wells Fargo
California
$211K -$1.55K -97 -0.9%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$193K -$35.3K -2,200 -18%
AG
49
Aperio Group
California
$154K +$27.2K +1,695 +28%
LPL Financial
50
LPL Financial
California
$131K +$8.01K +500 +8%
1
2
3 4 5

ARNA Hedge Fund Activity: Q1 2016 in Review

111 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2016, worth a combined $225M — down 8% from $245M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ARNA and 7 opened new positions — a net loss of 9 holders — while 35 trimmed existing stakes and 39 added.

The largest buyer was Wellington Management Group, adding an estimated $2.79M. The largest seller was Camber Capital Management, exiting entirely with an estimated $19.9M sold.

  • 111 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2016, down from 121 in Q4 2015.
  • Funds reported $225M of Arena Pharmaceuticals Inc stock for Q1 2016, down 8% quarter-over-quarter.
  • 7 funds opened new Arena Pharmaceuticals Inc positions in Q1 2016 and 16 closed out, a net change of -9 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2016 was Wellington Management Group, an estimated $2.79M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2016 was Camber Capital Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q1 2016.